Neil Stahl Net Worth & Insider Trades

Neil Stahl - EVP Research and Development, Regeneron Pharmaceuticals, Inc

As of December 20, 2022

What is Neil Stahl's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP Research and Development, Neil Stahl, is estimated to be about $138.67M . Neil Stahl owns about 57,400 units of Regeneron Pharmaceuticals, Inc common stock. In the last 19 years at Regeneron Pharmaceuticals, Inc, Neil Stahl has sold an estimated value of $369.62M worth.

What is Neil Stahl's Past Insider Trading?

Neil Stahl's largest purchase order was 95,000 units , worth over $25.69M on August 8, 2022. Neil Stahl's largest sale order was 95,335 units , worth over $58.23M on August 8, 2022. In total, Neil Stahl has made about 63 transactions over 19 years of their time at Regeneron Pharmaceuticals, Inc. Neil Stahl usually trades in December, with the busiest year in 2014, 2020 and 2012.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on March 27, 2023 by Bonnie L Bassler who sold 1,240 units worth $1.01M . In the last 20 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.55B and bought an estimated value of $3.54B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...